BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34606987)

  • 1. Assessment of intercontinents mutation hotspots and conserved domains within SARS-CoV-2 genome.
    Omotoso OE; Olugbami JO; Gbadegesin MA
    Infect Genet Evol; 2021 Dec; 96():105097. PubMed ID: 34606987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent of molecular variation in novel SARS-CoV-2 after the six-month global spread.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2021 Jul; 91():104800. PubMed ID: 33677109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of SARS-CoV-2 Envelope, Membrane, Nucleocapsid, and Spike Structural Proteins from the Beginning of the Pandemic to September 2020: A Global and Regional Approach by Epidemiological Week.
    Troyano-Hernáez P; Reinosa R; Holguín Á
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33557213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributory role of SARS-CoV-2 genomic variations and life expectancy in COVID-19 transmission and low fatality rate in Africa.
    Omotoso OE
    Egypt J Med Hum Genet; 2020; 21(1):72. PubMed ID: 38624543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant.
    Pachetti M; Marini B; Benedetti F; Giudici F; Mauro E; Storici P; Masciovecchio C; Angeletti S; Ciccozzi M; Gallo RC; Zella D; Ippodrino R
    J Transl Med; 2020 Apr; 18(1):179. PubMed ID: 32321524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal landscape of mutational frequencies in SARS-CoV-2 genomes of Bangladesh: possible implications from the ongoing outbreak in Bangladesh.
    Saha O; Islam I; Shatadru RN; Rakhi NN; Hossain MS; Rahaman MM
    Virus Genes; 2021 Oct; 57(5):413-425. PubMed ID: 34251592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative insight into the genomic landscape of SARS-CoV-2 and identification of mutations associated with the origin of infection and diversity.
    Mishra D; Suri GS; Kaur G; Tiwari M
    J Med Virol; 2021 Apr; 93(4):2406-2419. PubMed ID: 33347622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geographical distribution of SARS-CoV-2 amino acids mutations and the concomitant evolution of seven distinct clades in non-human hosts.
    Magateshvaren Saras MA; Patro LPP; Uttamrao PP; Rathinavelan T
    Zoonoses Public Health; 2022 Nov; 69(7):816-825. PubMed ID: 35614572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-synonymous mutations of SARS-CoV-2 leads epitope loss and segregates its variants.
    Gupta AM; Chakrabarti J; Mandal S
    Microbes Infect; 2020; 22(10):598-607. PubMed ID: 33049387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Substitutions in Spike and Nucleocapsid proteins of SARS-CoV-2 circulating in South America.
    Franco-Muñoz C; Álvarez-Díaz DA; Laiton-Donato K; Wiesner M; Escandón P; Usme-Ciro JA; Franco-Sierra ND; Flórez-Sánchez AC; Gómez-Rangel S; Rodríguez-Calderon LD; Barbosa-Ramirez J; Ospitia-Baez E; Walteros DM; Ospina-Martinez ML; Mercado-Reyes M
    Infect Genet Evol; 2020 Nov; 85():104557. PubMed ID: 32950697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.
    Saha I; Ghosh N; Pradhan A; Sharma N; Maity D; Mitra K
    Brief Bioinform; 2021 Mar; 22(2):1106-1121. PubMed ID: 33725111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan.
    Ghanchi NK; Nasir A; Masood KI; Abidi SH; Mahmood SF; Kanji A; Razzak S; Khan W; Shahid S; Yameen M; Raza A; Ashraf J; Ansar Z; Dharejo MB; Islam N; Hasan Z; Hasan R
    PLoS One; 2021; 16(8):e0256451. PubMed ID: 34464419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High Rate of Mutational Events in SARS-CoV-2 Genomes across Brazilian Geographical Regions, February 2020 to June 2021.
    de Souza UJB; Dos Santos RN; Campos FS; Lourenço KL; da Fonseca FG; Spilki FR; Corona-Ômica Br/McTi Network
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and epidemiological characteristics of SARS-CoV-2 in Africa.
    Lamptey J; Oyelami FO; Owusu M; Nkrumah B; Idowu PO; Adu-Gyamfi EA; Czika A; El-Duah P; Yeboah R; Sylverken A; Olasunkanmi OI; Owusu-Dabo E; Drosten C; Adu-Sarkodie Y
    PLoS Negl Trop Dis; 2021 Apr; 15(4):e0009335. PubMed ID: 33901167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haplotype distribution of SARS-CoV-2 variants in low and high vaccination rate countries during ongoing global COVID-19 pandemic in early 2021.
    Bui NN; Lin YT; Huang SH; Lin CW
    Infect Genet Evol; 2022 Jan; 97():105164. PubMed ID: 34848355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global SNP analysis of 11,183 SARS-CoV-2 strains reveals high genetic diversity.
    Yuan F; Wang L; Fang Y; Wang L
    Transbound Emerg Dis; 2021 Nov; 68(6):3288-3304. PubMed ID: 33207070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of SARS-CoV-2 Genomes from West Java, Indonesia.
    Fibriani A; Stephanie R; Alfiantie AA; Siregar ALF; Pradani GAP; Yamahoki N; Purba WS; Alamanda CNC; Rahmawati E; Rachman RW; Robiani R; Ristandi RB
    Viruses; 2021 Oct; 13(10):. PubMed ID: 34696527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 mutations: the biological trackway towards viral fitness.
    Majumdar P; Niyogi S
    Epidemiol Infect; 2021 Apr; 149():e110. PubMed ID: 33928885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key genetic elements, single and in clusters, underlying geographically dependent SARS-CoV-2 genetic adaptation and their impact on binding affinity for drugs and immune control.
    Salpini R; Alkhatib M; Costa G; Piermatteo L; Ambrosio FA; Di Maio VC; Scutari R; Duca L; Berno G; Fabeni L; Alcaro S; Ceccherini-Silberstein F; Artese A; Svicher V
    J Antimicrob Chemother; 2021 Jan; 76(2):396-412. PubMed ID: 33254234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.